Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Skip to content
lang_web

Seminar Title

 

Seminar M1 – Inspired by STOPP/START: a new prescription screening tool for adult patients

Affiliation

Clinic of Genolier / University of Geneva / Cranfield University

Country

Switzerland

1. Current Status, Position

Pierre-Olivier Lang is associate director of the Nescens centre of preventive medicine at the Clinic of Genolier in Switzerland.

2. Education

Pierre-Olivier Lang is a specialist in internal medicine, prevention and public health, and in the medicine of aging. He is Privatdozent at University of Geneva and an Associate Professor in “Translational Medicine” at Cranfield University (UK).

3. Research Area

Pierre-Olivier Lang’s research activities focus on:

  1. Preventing drug-drug, drug-disease and drug related-adverse outcomes in the aging and aged adult populations. He has contributed to the validation, spreading and transcultural adaptation of the STOPP-START1 set of criteria. He participates to the development and validation of the STOPP-START2 set of criteria.
  2. The aging of the immune system, its diagnosis and its regeneration and its impact on vaccine response and vaccine effectiveness.

Conflict of interest: None

×